What is viscosupplementation?

Viscosupplementation is a medical procedure involving the injection of a gel-like fluid containing hyaluronic acid derivatives directly into the knee joints. This fluid acts as a lubricant, reducing friction, inflammation, and pain, while also cushioning joint loads.

How big is the Viscosupplementation Market?

The global Viscosupplementation Market size was estimated at USD 3,562.9 Million in 2023 and is expected to reach USD 7,763.6 Million in 2033.

What is the Viscosupplementation Market growth?

The global Viscosupplementation Market is expected to grow at a compound annual growth rate of 8.1%. From 2024 To 2033

Who are the key companies/players in the Viscosupplementation Market?

Some of the key players in the Viscosupplementation Markets are Sanofi S.A., Anika Therapeutics, Inc., Seikagaku Corp., Zimmer Biomet, Smith & Nephew PLC, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., Fidia Farmaceutici S.p.A, Hoffmann-La Roche Ltd., Other Key Players.

What are the benefits of viscosupplementation?

Viscosupplementation offers comprehensive benefits, including smoother bone movement, reduced inflammation, alleviation of severe pain, improved joint range of motion, and chondroprotective effects. It also restores the rheological properties of synovial fluids.

What conditions does viscosupplementation treat?

Viscosupplementation is primarily used to treat osteoarthritis of the knee, but it can also be applied to osteoarthritis affecting the hip and hand joints.

Viscosupplementation Market Size, Growth

Global Viscosupplementation Market, By Dosage (Single Injection, Three Injection, Five Injection) By Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Other Applications) By End-Users (Hospitals, Orthopedics Clinics, Ambulatory Surgical Centers, and Other End Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

- Get a FREE Sample -

Our Clients